首页> 外文OA文献 >Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum

【2h】

Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum

机译：直肠癌直至手术的贝伐单抗和联合化疗（BACCHUS）：一项针对高危直肠癌患者的新辅助化疗的II期，多中心，开放标签，随机研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
R. Glynne-Jones; null null; N. Hava; V. Goh; S. Bosompem; J. Bridgewater; I. Chau; A. Gaya; H. Wasan; B. Moran; L. Melcher; A. MacDonald; M. Osborne; S. Beare; M. Jitlal; A. Lopes; M. Hall; N. West; P. Quirke; Wai-Lup Wong; M. Harrison;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum [J] . R. Glynne-Jones, N. Hava, V. Goh, BMC Cancer . 2015,第1期

机译：直肠癌直至手术的贝伐单抗和联合化学治疗（BACCHUS）：一项针对高危直肠癌患者的新辅助化疗的II期，多中心，开放标签，随机研究
2. 6518 ORAL Subgroup results from a randomised, double-blind, multicentre phase III study of bevacizumab in combination with cisplatingemcitabine in chemotherapy-naive patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): study BO17704 [J] . W.Eberhardt, M.Reck, J.vonPawel, European Journal of Cancer Supplements . 2007,第4期

机译：6518 ORAL亚组来自贝伐单抗联合顺铂emcitabine在未经化疗的初发性或复发性非鳞状非小细胞肺癌（NSCLC）患者中的随机，双盲，多中心III期研究结果：研究BO17704
3. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial (vol 18, pg 812, 2017) [J] . Gronchi A., Ferrari S., Quagliuolo V The lancet oncology . 2017,第6期

机译：组织型 - 大型软组织Sarcomas患者（ISG-STS 1001）患者的组织型 - 定制Neoadjuvant化疗（ISG-STS 1001）
4. Radiomics to Predict Response to Neoadjuvant Chemotherapy in Rectal Cancer: Influence of Simultaneous Feature Selection and Classifier Optimization [C] . S. Rosati, C. M. Gianfreda, G. Balestra, IEEE Life Sciences Conference . 2018

机译：放射学可以预测直肠癌对新辅助化疗的反应：同时特征选择和分类器优化的影响
5. Coregistration of serial breast MR studies for augmenting neoadjuvant chemotherapy response evaluation in breast cancer patients. [D] . Chittineni, Ruparani. 2008

机译：增强乳腺癌患者新系列辅助化疗反应评估的系列乳房MR研究的核心。
6. Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II multicentre open-label randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum [O] . R. Glynne-Jones, N. Hava, V. Goh, 2015

机译：直肠癌直至手术的贝伐单抗和联合化疗（BACCHUS）：一项针对高危直肠癌患者的新辅助化疗的II期多中心开放标签随机研究
7. Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum [O] . Glynne-Jones R, Hava N, Goh V, 2015

机译：Bevacizumab和直肠癌联合化疗直至手术（BaCCHUs）：一项II期，多中心，开放标签，随机研究的新辅助化疗单独用于直肠高危癌症患者

Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum

著录项

引文网络

相似文献

相关主题

期刊订阅